Similar Items: Modernizing disease assessment in prostate cancer trials: the Prostate Cancer Working Group 4 framework
- PET-MR Examination in Diagnosing Bone Metastases in Prostate Cancer
- Combining Serum PVT1 Exon 4A and Exon 9 with Serum Prostate-Specific Antigen Shows Potential for Improving Identification and Risk Stratification of Prostate Cancer
- Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer
- PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer
- Exploring Genetic Contributions to Prostate Cancer Risk in an Asian Population‐Based Study
- Immune Cell Infiltration and Causal Relationships with Prostate Cancer: A Transcriptomic and Mendelian Randomization Study